Citadel Advisors’s Biocept, Inc. BIOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-274
| Closed | -$2.79K | – | 6813 |
|
|
2023
Q1 | $2.79K | Sell |
274
-73
| -21% | -$744 | ﹤0.01% | 5665 |
|
|
2022
Q4 | $5.51K | Buy |
+347
| New | +$5.51K | ﹤0.01% | 5768 |
|
|
2022
Q3 | – | Sell |
-1,605
| Closed | -$45K | – | 7054 |
|
|
2022
Q2 | $45K | Buy |
1,605
+971
| +153% | +$27.2K | ﹤0.01% | 5538 |
|
|
2022
Q1 | $45K | Sell |
634
-1,231
| -66% | -$87.4K | ﹤0.01% | 5945 |
|
|
2021
Q4 | $203K | Buy |
1,865
+1,318
| +241% | +$143K | ﹤0.01% | 5470 |
|
|
2021
Q3 | $66K | Sell |
547
-70
| -11% | -$8.45K | ﹤0.01% | 6037 |
|
|
2021
Q2 | $77K | Buy |
+617
| New | +$77K | ﹤0.01% | 6074 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6980 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5782 |
|
|
2020
Q2 | – | Sell |
-157
| Closed | -$12K | – | 5484 |
|
|
2020
Q1 | $12K | Buy |
+157
| New | +$12K | ﹤0.01% | 4724 |
|
|
2018
Q2 | – | Sell |
-8
| Closed | -$21K | – | 4699 |
|
|
2018
Q1 | $21K | Buy |
+8
| New | +$21K | ﹤0.01% | 3867 |
|
|
2017
Q4 | – | Sell |
-2
| Closed | -$18K | – | 4395 |
|
|
2017
Q3 | $18K | Hold |
2
| – | – | ﹤0.01% | 3540 |
|
|
2017
Q2 | $30K | Buy |
2
+1
| +100% | +$15K | ﹤0.01% | 3454 |
|
|
2017
Q1 | $23K | Buy |
+1
| New | +$23K | ﹤0.01% | 3505 |
|
|
2016
Q4 | – | Sell |
-1
| Closed | -$18K | – | 4249 |
|
|
2016
Q3 | $18K | Buy |
+1
| New | +$18K | ﹤0.01% | 3460 |
|
|
2016
Q1 | – | Hold |
0
| – | -$14K | – | 4121 |
|
|
2015
Q4 | – | Sell |
-1
| Closed | -$41K | – | 3738 |
|
|
2015
Q3 | $41K | Buy |
+1
| New | +$41K | ﹤0.01% | 3588 |
|